BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van der Wijst MG, Brown R, Rots MG. Nrf2, the master redox switch: The Achilles' heel of ovarian cancer? Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2014;1846:494-509. [DOI: 10.1016/j.bbcan.2014.09.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Hou D, Liu Z, Xu X, Liu Q, Zhang X, Kong B, Wei JJ, Gong Y, Shao C. Increased oxidative stress mediates the antitumor effect of PARP inhibition in ovarian cancer. Redox Biol 2018;17:99-111. [PMID: 29684820 DOI: 10.1016/j.redox.2018.03.016] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
2 Cheng J, Guo J, Wang Z, North BJ, Tao K, Dai X, Wei W. Functional analysis of Cullin 3 E3 ligases in tumorigenesis. Biochim Biophys Acta Rev Cancer 2018;1869:11-28. [PMID: 29128526 DOI: 10.1016/j.bbcan.2017.11.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
3 Zeng X, Li X, Xu C, Jiang F, Mo Y, Fan X, Li Y, Jiang Y, Li D, Huang M, Bi H. Schisandra sphenanthera extract (Wuzhi Tablet) protects against chronic-binge and acute alcohol-induced liver injury by regulating the NRF2-ARE pathway in mice. Acta Pharm Sin B 2017;7:583-92. [PMID: 28924552 DOI: 10.1016/j.apsb.2017.04.002] [Cited by in F6Publishing: 24] [Reference Citation Analysis]
4 Nitti M, Ivaldo C, Traverso N, Furfaro AL. Clinical Significance of Heme Oxygenase 1 in Tumor Progression. Antioxidants (Basel) 2021;10:789. [PMID: 34067625 DOI: 10.3390/antiox10050789] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Roininen N, Haapasaari KM, Karihtala P. The Role of Redox-Regulating Enzymes in Inoperable Breast Cancers Treated with Neoadjuvant Chemotherapy. Oxid Med Cell Longev 2017;2017:2908039. [PMID: 29348788 DOI: 10.1155/2017/2908039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
6 Surai PF. Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives. Antioxidants (Basel) 2015;4:204-47. [PMID: 26785346 DOI: 10.3390/antiox4010204] [Cited by in Crossref: 227] [Cited by in F6Publishing: 194] [Article Influence: 32.4] [Reference Citation Analysis]
7 Sun X, Wang Q, Wang Y, Du L, Xu C, Liu Q. Brusatol Enhances the Radiosensitivity of A549 Cells by Promoting ROS Production and Enhancing DNA Damage. Int J Mol Sci 2016;17:E997. [PMID: 27347930 DOI: 10.3390/ijms17070997] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 7.7] [Reference Citation Analysis]
8 Barreiro-Alonso A, Lamas-Maceiras M, Rodríguez-Belmonte E, Vizoso-Vázquez Á, Quindós M, Cerdán ME. High Mobility Group B Proteins, Their Partners, and Other Redox Sensors in Ovarian and Prostate Cancer. Oxid Med Cell Longev 2016;2016:5845061. [PMID: 26682011 DOI: 10.1155/2016/5845061] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
9 Nitti M, Piras S, Marinari UM, Moretta L, Pronzato MA, Furfaro AL. HO-1 Induction in Cancer Progression: A Matter of Cell Adaptation. Antioxidants (Basel) 2017;6:E29. [PMID: 28475131 DOI: 10.3390/antiox6020029] [Cited by in Crossref: 79] [Cited by in F6Publishing: 83] [Article Influence: 15.8] [Reference Citation Analysis]
10 Hyter S, Hirst J, Pathak H, Pessetto ZY, Koestler DC, Raghavan R, Pei D, Godwin AK. Developing a genetic signature to predict drug response in ovarian cancer. Oncotarget 2018;9:14828-48. [PMID: 29599910 DOI: 10.18632/oncotarget.23663] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Mostafavi-Pour Z, Ramezani F, Keshavarzi F, Samadi N. The role of quercetin and vitamin C in Nrf2-dependent oxidative stress production in breast cancer cells. Oncol Lett 2017;13:1965-73. [PMID: 28454351 DOI: 10.3892/ol.2017.5619] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]
12 Sova M, Saso L. Design and development of Nrf2 modulators for cancer chemoprevention and therapy: a review. Drug Des Devel Ther 2018;12:3181-97. [PMID: 30288023 DOI: 10.2147/DDDT.S172612] [Cited by in Crossref: 35] [Cited by in F6Publishing: 19] [Article Influence: 8.8] [Reference Citation Analysis]
13 Zhang Q, Zhang ZY, Du H, Li SZ, Tu R, Jia YF, Zheng Z, Song XM, Du RL, Zhang XD. DUB3 deubiquitinates and stabilizes NRF2 in chemotherapy resistance of colorectal cancer. Cell Death Differ 2019;26:2300-13. [PMID: 30778200 DOI: 10.1038/s41418-019-0303-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
14 Bai X, Chen Y, Hou X, Huang M, Jin J. Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters. Drug Metab Rev 2016;48:541-67. [PMID: 27320238 DOI: 10.1080/03602532.2016.1197239] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 13.0] [Reference Citation Analysis]
15 Czogalla B, Kahaly M, Mayr D, Schmoeckel E, Niesler B, Hester A, Zeder-Göß C, Kolben T, Burges A, Mahner S, Jeschke U, Trillsch F. Correlation of NRF2 and progesterone receptor and its effects on ovarian cancer biology. Cancer Manag Res 2019;11:7673-84. [PMID: 31616183 DOI: 10.2147/CMAR.S210004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Bayer JL, Spitz DR, Christensen D, McCormick ML, Farley D, DeGeest K, Damoush L, Aust S, Sood AK, Lutgendorf SK. Biobehavioral and neuroendocrine correlates of antioxidant enzyme activity in ovarian carcinoma. Brain Behav Immun 2015;50:58-62. [PMID: 25989110 DOI: 10.1016/j.bbi.2015.04.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
17 van der Wijst MG, Huisman C, Mposhi A, Roelfes G, Rots MG. Targeting Nrf2 in healthy and malignant ovarian epithelial cells: Protection versus promotion. Mol Oncol 2015;9:1259-73. [PMID: 25841766 DOI: 10.1016/j.molonc.2015.03.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
18 Czogalla B, Kahaly M, Mayr D, Schmoeckel E, Niesler B, Kolben T, Burges A, Mahner S, Jeschke U, Trillsch F. Interaction of ERα and NRF2 Impacts Survival in Ovarian Cancer Patients. Int J Mol Sci 2018;20:E112. [PMID: 30597961 DOI: 10.3390/ijms20010112] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
19 Perna A, De Luca A, Adelfi L, Pasquale T, Varriale B, Esposito T. Effects of different extracts of curcumin on TPC1 papillary thyroid cancer cell line. BMC Complement Altern Med 2018;18:63. [PMID: 29448931 DOI: 10.1186/s12906-018-2125-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
20 Kleinschmidt EG, Miller NLG, Ozmadenci D, Tancioni I, Osterman CD, Barrie AM, Taylor KN, Ye A, Jiang S, Connolly DC, Stupack DG, Schlaepfer DD. Rgnef promotes ovarian tumor progression and confers protection from oxidative stress. Oncogene 2019;38:6323-37. [PMID: 31308489 DOI: 10.1038/s41388-019-0881-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
21 Gomes VJ, Rezeck Nunes P, Haworth SM, Sandrim VC, Peraçoli JC, Peraçoli MTS, Carlström M. Monocytes from preeclamptic women previously treated with silibinin attenuate oxidative stress in human endothelial cells. Hypertens Pregnancy 2021;40:124-32. [PMID: 33586558 DOI: 10.1080/10641955.2021.1884258] [Reference Citation Analysis]
22 Furfaro AL, Traverso N, Domenicotti C, Piras S, Moretta L, Marinari UM, Pronzato MA, Nitti M. The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance. Oxid Med Cell Longev 2016;2016:1958174. [PMID: 26697129 DOI: 10.1155/2016/1958174] [Cited by in Crossref: 113] [Cited by in F6Publishing: 121] [Article Influence: 16.1] [Reference Citation Analysis]